How to Read and Trade AI Powered Stock Charts
Enter Stock Symbol to View AI powered Stock Chart
StockChartsAI.com
All Chart Prices as of Previous Day CloseBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
12/07/2023 16:10:00 EST
Elanco Animal Health (ELAN)
Industry: Drug Manufacturers - Specialty & Generic
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 30 trading days, ELAN has been trading in a range between $12.05 and $8.60 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
ELAN is trading below resistance at $12.83, about 0% to the upside. There is support at $11.78 -8% to the downside. If it can break above the resistance, it could have some more upside. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
Elanco Animal Health (ELAN) entered a Green zone 22 days ago on the AI powered stock chart. Wall Street analysts have a recent rating of 3.500, which is a Buy. The current analyst target price is $13.81, which gives it a potential upside of 8.14 % from the recent price of 12.77. The stock is trading 15.04% (potential upside) below its 52 week high of $14.69 and 62.06 % (potential downside) above its 52 week low of $7.88 - based on the recent price.
Company Summary
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations.
News
| Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Evercore ISI 6th Annual HealthCONx Conference, November 28-29, 2023. Todd Young, Executive Vice President and CFO, will participate in a fireside chat on Wednesday, November 29 at 8:20 a.m. ET. A live audio webcast will be available in the “Events and Presentations” section of Elanco's investor website. A replay will be available for approximately 30 days. ABOUT ELANCO Elanco Animal Health Incorpor. Source: Business Wire Mon, 27 Nov 2023 08:00:00 -0500 Sentiment: Neutral |
| Why Elanco Animal Health Stock Was Pure Catnip to Investors This Week The pet wellness company posted its latest set of quarterly earnings. It beat the consensus analyst estimates for both revenue and profitability. Source: The Motley Fool Fri, 10 Nov 2023 17:20:36 -0500 Sentiment: Positive |
| Elanco Animal Health Incorporated (ELAN) Q3 2023 Earnings Call Transcript Elanco Animal Health Incorporated (NYSE:ELAN ) Q3 2023 Earnings Conference Call November 7, 2023 8:00 AM ET Company Participants Katy Grissom - Head of IR Jeff Simmons - President and CEO Todd Young - CFO Conference Call Participants Michael Ryskin - Bank of America Jon Block - Stifel Erin Wright - Morgan Stanley Chris Schott - JPMorgan Umer Raffat - Evercore ISI Nathan Rich - Goldman Sachs Brandon Vazquez - William Blair Balaji Prasad - Barclays Operator Good morning. My name is Krista, and I'll be your conference operator today. Source: Seeking Alpha Tue, 07 Nov 2023 12:08:09 -0500 Sentiment: Neutral |
| Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q3 Earnings While the top- and bottom-line numbers for Elanco Animal Health Incorporated (ELAN) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Source: Zacks Investment Research Tue, 07 Nov 2023 10:31:10 -0500 Sentiment: Neutral |
| Elanco Animal Health Reports Third Quarter 2023 Results GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the third quarter of 2023, provided guidance for the fourth quarter of 2023, and updated guidance for the full year 2023. “Elanco delivered a strong third quarter across both pet health and farm animal, with revenue, adjusted EBITDA, and adjusted EPS growth. Constant currency revenue growth of 5 percent was driven by accelerating contribution from innovation, stabilizing core v. Source: Business Wire Tue, 07 Nov 2023 06:33:00 -0500 Sentiment: Neutral |
Technicals 52 Week Hi: 14.69 52 Week Low: 7.88 Beta: 1.141 50 Day MA: 10.488 200 Day MA: 10.4013 Earnings / Revenue Trends Qtr Earnings Growth YOY: 1.097 Qtr Revenue Growth YOY: 0.041 Forward PE: 14.3062 Trailing PE: 0